External Beam Radiotherapy for Prostate Cancer Increases Bladder-Cancer Risk External Beam Radiotherapy for Prostate Cancer Increases Bladder-Cancer Risk
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 5, 2018 Category: Surgery Tags: Hematology-Oncology News Source Type: news
Do Some Prostate Cancer Therapies Raise Patients ’ Risks for Bladder Cancer?
Treatment for prostate cancer with external beam radiotherapy was found to be associated with an increased risk for development of bladder cancer when compared with radical prostatectomy. (Source: CancerNetwork)
Source: CancerNetwork - October 18, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
Study: Best Treatments for Basal Cell Carcinoma
When treating low-risk primary basal cell carcinoma (BCC), surgery and external beam radiation yield a better chance of a cure and a lower recurrence rate compared with other treatment modalities. This is the finding of a recent meta-analysispublished in theAnnals of Internal Medicine. (Source: CancerNetwork)
Source: CancerNetwork - October 17, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news
New ASTRO/ASCO/AUA guideline for prostate cancer supports shortened radiation therapy
(American Society for Radiation Oncology) Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer. Developed by a panel of experts from ASTRO, ASCO and AUA, the new guideline recommends offering patients a treatment option known as hypofractionated radiation therapy as an alternative to longer, conventional courses of radiation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 11, 2018 Category: International Medicine & Public Health Source Type: news
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
Mr. Alecxih to Lead Company's Commercial Expansion
CLEVELAND, Oct. 2, 2018 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image ... Devices, Oncology, Radiology, Personnel ViewRay, MRIdian, radiation therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 2, 2018 Category: Pharmaceuticals Source Type: news
Review: Treatments for Primary Basal Cell Carcinoma Compared
Similarly low recurrence rates for excision, Mohs sx, curettage and diathermy, external - beam radiation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 18, 2018 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news
Review: Treatments for Primary Basal Cell Carcinoma Compared
TUESDAY, Sept. 18, 2018 -- For patients with primary basal cell carcinoma (BCC), estimated recurrence rates are similarly low for excision, Mohs surgery, curettage and diathermy, and external-beam radiation, according to a review and meta-analysis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2018 Category: Pharmaceuticals Source Type: news
Radiofrequency Ablation Fixes Mesothelioma Recurrence in Case Study
Radiofrequency ablation (RFA) has been used successfully in Japan to treat post-surgery recurrence of malignant pleural mesothelioma, according to a case study published recently by the Society of Thoracic Surgeons.
Although RFA has been utilized for several years to treat various thoracic lesions, the study authors believe this is the first time it worked effectively with mesothelioma cancer cells.
“It shows promising efficacy,” the authors wrote. “Radiofrequency should be considered an option for treating recurrence of MPM [malignant pleural mesothelioma].”
RFA is a minimally invasive medical procedure that utili...
Source: Asbestos and Mesothelioma News - August 15, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
PSA'Bounce' Probably Not an Adverse Effect of Radiation PSA'Bounce' Probably Not an Adverse Effect of Radiation
Dr Chodak discusses significant findings on the implications of PSA bounce after external beam radiation therapy.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 6, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news
Aggressive Approach to High-Grade Prostate Cancer May Be Best Aggressive Approach to High-Grade Prostate Cancer May Be Best
High-dose radiotherapy plus androgen-deprivation treatment (ADT) delivered superior outcomes compared with standard external-beam radiation and ADT or radical prostatectomy alone.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Xcision Receives FDA 510(k) Clearance for the GammaPod Stereotactic Radiotherapy System for Breast Cancer
COLUMBIA, Md., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatme... Devices, Oncology, FDA Xcision Medical Systems, GammaPod, Stereotactic, Radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2018 Category: Pharmaceuticals Source Type: news
Clinical Commissioning Policy: Hypofractionated external beam radiotherapy in the treatment of localised prostate cancer (adults)
This document sets out NHS England ' s criteria for commissioning hypofractionated external beam radiotherapy for localised prostate cancer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 10, 2017 Category: Consumer Health News Source Type: news
Androgen Deprivation, Radiation After Prostatectomy Tied to Longer Survival Androgen Deprivation, Radiation After Prostatectomy Tied to Longer Survival
Survival after radical prostatectomy for prostate cancer is better among men who undergo androgen deprivation therapy (ADT) and external beam radiation therapy (EBRT), according to a retrospective analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 9, 2017 Category: Surgery Tags: Urology News Source Type: news
ASTRO: EBRT Underused in Liver Cancer Patients Awaiting Transplant
Only 3.6 percent of patients received external - beam radiation therapy alone or in combination with other liver - directed bridging therapies (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Surgery, Conference News, Source Type: news
Studies aid choice of therapy for localised prostate cancer
Radical prostatectomy associated with worse sexual function and incontinence than external beam radiotherapy Related items fromOnMedica Trial of robotic surgery successful for prostate cancer New risk estimation for prostate cancer improves accuracy Special scan may curb need for first biopsy in 1 in 4 men with prostate cancer New non-surgical treatment for early prostate cancer shows promise (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 22, 2017 Category: UK Health Source Type: news
